Wikidata entity: Q64397731
Quantities
| P4135 | maximum age | 75 |
| P2899 | minimum age | 18 |
| P1132 | number of participants | 31 |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2016-05-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q170990 (arthritis) | arthritis |
| P6153 | research site | ... | Q30269584 (Altoona Center for Clinical Research) | Altoona Center for Clinical Research |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q30270444 (Suncoast Clinical Research) | Suncoast Clinical Research |
| P580 | start time | ... | 2015-04-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Phase 2a, 4-Week, Double-Blind, Proof-of-Concept Efficacy and Safety Study of ACP-196 Versus Placebo in Subjects With Active Rheumatoid Arthritis on Background Methotrexate | ??? |
| P3098 | ClinicalTrials.gov ID | NCT02387762 |
Why not click here or view trends?
log id: 4732530